Patients ( n = 463 ) in this 36 week study ( 10 week acute and 26 week extension treatment ) received duloxetine 60mg QD ( n = 108 ) , duloxetine 30mg QD ( n = 116 ) , fluoxetine 20mg QD ( n = 117 , active control ) , or placebo ( n = 122 ) .